Results 21 to 30 of about 227,291 (309)

Outcome of adjuvant radiotherapy after total hysterectomy in patients with uterine leiomyosarcoma or carcinosarcoma: a SEER-based study

BMC Cancer, 2019
Background The clinical impact of adjuvant radiotherapy on uterine sarcoma is unclear, and may depend on the histological type. Hence, the aim of this study was to evaluate clinical outcomes of adjuvant radiotherapy after total hysterectomy in patients ...
Yuan Li, Haitao Ren, Junmei Wang
doaj   +1 more source

Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results [PDF]

, 2016
Aim: To report long term oncologic outcomes after adjuvant radiotherapy (RT) for stage I seminoma. Method: We reviewed the complete data set for all patients treated at our institute between 1988 and 2005 for stage I seminoma with adjuvant RT after ...
De Felice, Francesca, Gravina, Giovanni Luca, Marampon, Francesco, Musio, Daniela, Tombolini, Vincenzo   +4 more
core   +2 more sources

Role of radiation therapy in node‐negative esophageal cancer: A propensity‐matched analysis

Thoracic Cancer, 2020
Background This study investigated the prognostic impact of (neo‐)adjuvant radiation therapies in early stage esophageal cancer. Methods A retrospective analysis using the Surveillance, Epidemiology, and End Results (SEER) database was conducted from ...
Hui‐Jiang Gao, Yu‐Cheng Wei, Lei Gong, Nan Ge, Bin Han, Guo‐Dong Shi, Zhen‐Tao Yu   +6 more
doaj   +1 more source

Adjuvant Radiation Therapy Alone for HPV Related Oropharyngeal Cancers with High Risk Features. [PDF]

PLoS ONE, 2016
Current standard of care for oropharyngeal cancers with positive surgical margins and/or extracapsular extension is adjuvant chemoradiotherapy. It is unknown whether HPV+ oropharyngeal cancer benefits from this treatment intensification.To investigate ...
William Su, Jerry Liu, Brett A Miles, Eric M Genden, Krzysztof J Misiukiewicz, Marshall Posner, Vishal Gupta, Richard L Bakst   +7 more
doaj   +1 more source

Defining a positive circumferential resection margin in oesophageal cancer and its implications for adjuvant treatment [PDF]

, 2013
A positive circumferential resection margin (CRM) has been associated with a poorer prognosis in oesophageal and oesophagogastric junctional (OGJ) cancer. The College of American Pathologists defines the CRM as positive if tumour cells are present at the
Adam, Adamina, Agresti, American Joint Committee on Cancer, Austin, Courrech Staal, Cox, Deeter, Dexter, Gertler, Griffiths, Harvin, International Union Against Cancer, Jemal, Kaplan, Khan, Law, Mapstone, Medical Research Council Oesophageal Cancer Working Group, Pultrum, Quirke, Reid, Rice, Rosenbaum, Royston, Rubin, Sagar, Saha, Salih, Scheepers, Sujendran, van Hagen, Verhage, Wibe   +33 more
core   +1 more source

The Selection of Treatment Modality for Breast Ductal Carcinoma In Situ: Experience From a Single Institution

Cancer Control, 2021
Purpose: Although breast conservation surgery(BCS) followed by adjuvant radiotherapy is now the mainstream treatment method for breast ductal carcinoma in situ(DCIS), mastectomy is still performed in some patients who refuse to undergo radiation. However,
Kai-yun You MD, Zhuo-fei Bi MD, Yu-jia Ma BD, Yong-lin Mao BD, Wei-liang Zou BD, Yi-min Liu MD, He-rui Yao MD   +6 more
doaj   +1 more source

Adjuvant Radiotherapy in Endometrial Carcinoma

The Oncologist, 2005
Abstract The CME activity for this article is forthcoming. Access and take the CME test online and receive 1 hour of AMA PRA category 1 credit at CME.TheOncologist.com Endometrial cancer is a common female malignancy, affecting approximately 40,000 women per year.
David T, Shaeffer, Marcus E, Randall
openaire   +2 more sources

The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate model [PDF]

, 2009
To study whether the effects of prognostic factors associated with the occurrence of distant metastases (DM) at primary diagnosis change after the incidence of loco-regional recurrences (LRR) among women treated for invasive stage I or II breast cancer ...
A Fourquet, AC Voogd, B Fisher, B Fisher, B Fisher, C Vrieling, C. J. van de Velde, D Cowen, E Touboul, Early Breast Cancer Trialists’ Collaborative Group, G Coulombe, G. H. de Bock, H Bartelink, H Kemperman, H Putter, H. Bartelink, H. Putter, HM Nielsen, I Soerjomataram, J Dongen Van, J Engel, J Hage Van der, J Hage Van der, J Ragaz, J. A. van der Hage, J. Bonnema, JA Dongen Van, JA Dongen Van, JG Nes Van, L Livi, M Clarke, M Leest Van der, M Sangen Van der, MA Bollet, N Kroman, P Broet, PC Clahsen, PH Elkhuizen, PH Elkhuizen, R Arriagada, R Arriagada, RS Punglia, U Veronesi, WS Halsted   +43 more
core   +4 more sources

Timing of Early Salvage Therapy for Patients With Biochemical Relapse of Prostate Carcinoma

Oncology Reviews, 2023
Between 25% and 33% of patients after radical prostatectomy experience a relapse of the disease. The risk of relapse increases in patients with risk factors up to 50%–80%.
Soňa Argalácsová, Michal Vočka, Otakar Čapoun, Lukáš Lambert   +3 more
doaj   +1 more source

Successful role of adjuvant radiotherapy in a rare case of tracheal inflammatory myofibroblastic tumor: a case report [PDF]

, 2019
BACKGROUND:: Inflammatory myofibroblastic tumor (IMT) is a rare benign cancer that can express a more aggressive phenotype related to the genetic mutation of the anaplastic lymphoma kinase receptor (ALK). Involvement of trachea is extremely rare and due
Abate, Gessica, Bulzonetti, Nadia, D’Urso, Pasqualina, Lisi, Roberto, Marampon, Francesco, Martinetti, Maria Teresa, Siniscalchi, Benedetta, Tombolini, Vincenzo   +7 more
core   +1 more source